Jill Swofford

Jill Swofford is a seasoned professional in the pharmaceutical industry with extensive experience in patient access and specialty sales. Currently serving as Regional Patient Access Manager at Neurocrine Biosciences since January 2019, Swofford previously excelled as a NeuroPsych Account Specialist, where accomplishments included the successful launch of Ingrezza in 2018 and achieving a national ranking of #2. Prior experience includes roles at Otsuka Pharmaceutical Companies as Assure Program Manager for Reimbursement and Patient Support, and Account Manager at Novartis, where Swofford was instrumental in launching Fanapt within key healthcare facilities. Additional experience was gained at Eli Lilly and Company as an Account Based Neuroscience Specialty Representative. Swofford holds a Bachelor of Arts in Speech Communication from St. Catherine University.